Background Image
Table of Contents Table of Contents
Previous Page  25 / 70 Next Page
Information
Show Menu
Previous Page 25 / 70 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016

AFRICA

295

Methods

A total of 4 800 patients identified during routine coronary

angiograms in our clinic between January 2010 and 2013 were

included in the study. The study was planned to be prospective

and was approved by the local ethics committee. After coronary

angiography, the patients were informed about the study and

written consents were given.

Sixty-two patients with isolated CAE, 57 with normal

coronary angiograms (NCA), 73 with severe coronary artery

disease (CAD), and 95 with stenosis of at least one coronary

artery and CAE (CAD

+

CAE) were included in the study. All of

the patients were questioned on their cardiovascular risk factors

and medication used. Routine biochemical and haematological

laboratory tests were done.

Previous history of myocardial infarction, percutaneous

coronary intervention, left ventricular hypertrophy, left

ventricular dysfunction [ejection fraction (EF)

<

50%], moderate

to severe valvular disease, rhythms other than sinus, congenital

heart disease, chronic obstructive lung disease and/or cor

pulmonale, chronic systemic illness, active infection, renal failure,

neoplastic disease, antioxidant drug usage and alcohol abuse

were the exclusion criteria.

Coronary angiography was performed on a Siemens Axiom

Artis angiography device with standard Seldinger’s technique

using isohexol. In order to evaluate each coronary artery, at

least four views from the left and two views from the right side

were taken. Patients were allocated into four groups: patients

with CAD, those with isolated CAE, those with CAD

+

CAE,

and subjects with normal coronary angiograms. Angiographic

images were evaluated by two independent researchers.

Isolated CAE was defined as dilatation of at least one

epicardial coronary artery to 1.5 times the reference vessel

diameter and absence of critical stenosis (

>

50%) in any

of the coronary arteries. NCA were defined as the absence

of angiographic atherosclerosis during routine coronary

angiography; 60% or greater stenosis in at least one epicardial

coronary artery was defined as CAD. CAD

+

CAE was defined

as 60% or greater stenosis in at least one epicardial coronary

artery and the presence of ectasia in any of the coronary arteries.

Serum Mg levels were measured in mg/dl after 12 hours

of fasting. Haemograms, renal and liver function tests, lipid

profiles, serum glucose and electrolytes and thyroid stimulating

hormone (TSH) levels were also evaluated in all patients.

Statistical analysis

Statistical analysis was performed using the SPSS 14 (SPSS

Inc, Chicago, IL, USA) statistics program. Data are given as

percentages and mean

±

standard deviation. ANOVA and

post

hoc

Tukey tests were used in the comparison of parametric

variables between groups. A chi-squared test was performed

in the comparison of non-parametric values and percentages.

Statistical significance level was taken as

p

0.05.

Results

The mean age was 62

±

10 years in the CAE patients, 61

±

11 years in CAD patients, 64

±

8 years in those with CEA

+

CAD, and 59

±

8 years in the NCA patients. There was no

statistically significant difference between the groups in terms of

age, hypertension, smoking, hyperlipidaemia, diabetes mellitus,

family history of CAD, and medications used (Table 1).

Serum glucose, calcium, TSH, urea, total cholesterol,

triglycerides, low-density lipoprotein (LDL) cholesterol, sodium

and potassium levels were similar in both groups (Table 2).

Serum creatinine level was within normal limits in all patients,

however creatinine values were statistically lower in the NCA

group (

p

=

0.024). High-density lipoprotein (HDL) cholesterol

levels were lowest in the CAD patients and highest in the isolated

ectasia group, and this difference was statistically significant (

p

=

0.003).

Serum Mg levels were 1.90

±

0.19 mg/dl in isolated CAE

patients, 1.75

±

0.19 mg/dl in those with CAD, 1.83

±

0.20 mg/

dl in those with CAD

+

CAE, and 1.80

±

0.16 mg/dl in the NCA

group. These results showed that Mg levels were higher in the

ectasia patients with or without CAD.

Discussion

Mg is a divalent cation with powerful vasodilatory effects. In our

study, serumMg levels were found to be statistically higher in the

ectasia patients with or without CAD.

CAE is dilatation of the coronary arteries to at least 1.5 times

normal, and the basic pathogenic mechanism is destruction of

the musculo-elastic layers of the arterial tunica media, and the

accumulation of collagen in place of elastin, leading to thinning

of the arterial wall.

1,5,10

Injury of the media causes decreased

stress tolerance of the vessel wall to intraluminar pressure,

leading to progressive dilatation and ectasia formation.

10,11

In a

pathological examination, atherosclerosis is detected in more

than 50% of patients, however connective tissue disorders and

vasculitides can also be present.

11

CAE can be divided into four different types according to the

classification of Markis and colleagues. Type 1 indicates diffuse

ectasia in two to three different vessels, type 2 shows diffuse

disease in one vessel and local disease in another, type 3 is diffuse

disease in one vessel, and type 4 indicates localised or segmental

ectasia. In our study there were 24 (16%) patients with type 1

Table 1. Comparisons of cardiovascular risk factors and the

medications used

Parameters

Isolated

CAE

(

n

=

62)

CAD

(n

=

73)

CAD

+

CAE

(

n

=

95)

NCA

(

n

=

57)

p

-value

Age (years)

62

±

10 61

±

11 64

±

8 59

±

8 0.062

Gender (M/F)

45/17 39/34 76/19 17/40 0.000

Hypertension (

n

)

43

56

74

35

0.119

Diabetes mellitus (

n

)

13

21

25

12

0.648

Hyperlipidaemia (

n

)

11

13

29

9

0.080

Family history of

CAD (

n

)

18

25

36

16

0.543

Smoking (

n

)

33

32

49

24

0.482

Calcium channel

blockers (

n

)

12

20

23

12

0.744

Beta-blockers (

n

)

24

20

38

12

0.051

Angiotensin converting

enzyme inhibitors (

n

)

21

16

33

11

0.084

Angiotensin receptor

blockers (

n

)

17

26

32

14

0.471

Diuretics (

n

)

15

22

40

16

0.084

Oral antidiabetic (

n

)

11

13

16

10

0.998